IMM 1.59% 31.0¢ immutep limited

chemotherapy can boost cancer: study, page-2

  1. 3,665 Posts.
    lightbulb Created with Sketch. 312
    Hi solusnauta. What you have hit upon is "the holy grail" IMO, and it is something I have questioned PRR management about. The following is an email I sent to Dr Frazer in August last year:

    "Hi Neil,

    After doing some research, I have come to realize CVac's potential as a preventative, rather than a theraputic, vaccine.
    Can you answer any of the following questions for me?

    - Have you done any testing pre chemotherapy? No
    - If so, can you tell me what the results were?
    - If not, do you plan on conducting these trials in the future? After we obtain approval, we may broaden out the times of administration in additional clinical studies.
    - What would be the proccess required to gain FDA approval, ie full PH I, II AND III? It's a difficult question. We'd probably need to start with concomitant administration with chemotherapy and work back from there.
    - Will the current Ph III testing only allow you to administer CVac post chemotherapy? For EU, US and Australia-Yes"

    One day...hopefully...surely...common sense will prevail.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
-0.005(1.59%)
Mkt cap ! $450.9M
Open High Low Value Volume
31.5¢ 31.8¢ 31.0¢ $897.5K 2.872M

Buyers (Bids)

No. Vol. Price($)
9 79201 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 138883 3
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.